VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Vogenx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 17, 2026
$15.92+1.39 (+9.57%)
Close on Oct 19, 2026
- Market cap
- $86.79M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
5 of Vogenx's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 7, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 21, 2026 | Sep 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Sep 17, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2026 | Aug 19, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |